BioCardia Inc.

NASDAQ: BCDA · Real-Time Price · USD
1.90
0.01 (0.53%)
At close: Aug 15, 2025, 3:59 PM
1.92
0.98%
After-hours: Aug 15, 2025, 07:42 PM EDT

BioCardia Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
58K 61K 116K 129K 428K 468K 477K 570K 425K 1.36M 1.35M 1.32M 1.93M 1.03M 1.01M 982K 195K 153K
Cost of Revenue
431K 433K 430K 425K 421K 416K 411K 12.21M 12.21M 14.6M 14.59M 4.8M 6.94M 6.8M 8.56M 8.77M 9M 8.86M
Gross Profit
-431K -430K -372K -354K 7K 52K 66K -11.64M -11.78M -13.25M -13.24M -3.48M -5M -5.78M -7.54M -7.79M -8.81M -8.71M
Operating Income
-8.85M -8.45M -8M -7.76M -8.61M -10.41M -11.64M -12.58M -13.04M -12.08M -11.9M -12.34M -11.99M -12.98M -12.63M -12.67M -13.81M -13.89M
Interest Income
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 1K 3K 5K 9K 10K 9K 9K
Pretax Income
-8.79M -8.39M -7.95M -7.72M -8.56M -10.34M -11.57M -12.53M -13.01M -12.08M -11.91M -12.34M -11.99M -12.98M -12.62M -12.15M -13.29M -13.38M
Net Income
-8.79M -8.39M -7.95M -7.72M -8.56M -10.34M -11.56M -12.53M -13.01M -12.08M -11.91M -12.34M -11.99M -12.98M -12.63M -12.15M -13.29M -13.38M
Selling & General & Admin
3.61M 3.78M 3.67M 3.71M 3.96M 4.29M 4.39M 4.38M 4.42M 4.41M 4.42M 4.92M 5.08M 5.11M 5.09M 4.88M 5M 5.18M
Research & Development
5.24M 4.68M 4.39M 4.13M 5.07M 6.58M 7.73M 8.77M 9.04M 9.03M 8.83M 8.75M 8.85M 8.9M 8.56M 8.77M 9M 8.86M
Other Expenses
-218K -324K -430K -425K -421K -287K -172K -77K 30K 1K -6K 3K 2K 5K 2K 2K -1K -4K
Operating Expenses
8.64M 8.13M 7.63M 7.41M 8.61M 10.56M 11.91M 13.04M 13.46M 13.44M 13.25M 13.67M 13.93M 14.01M 13.64M 13.65M 14M 14.04M
Interest Expense
n/a n/a n/a 9K 9K 9K 9K 10K 10K 11K 11K 1K 1K n/a n/a 1K 1K 1K
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
8.85M 8.46M 8.06M 7.83M 9.03M 10.88M 12.12M 13.15M 13.46M 13.44M 13.25M 13.67M 13.93M 14.01M 13.64M 13.65M 14M 14.04M
Income Tax Expense
n/a n/a n/a n/a n/a n/a -9K 1K -2K -1K 6K 2K 1K -4K -9K -15K -10K -9K
Shares Outstanding (Basic)
5.06B 2.74M 2.74M 2.83M 1.88M 1.68M 1.5M 1.44M 1.36M 1.34M 1.22M 1.19M 1.18M 1.14M 1.14M 1.14M 1.14M 1.1M
Shares Outstanding (Diluted)
5.06B 2.74M 2.74M 2.83M 1.88M 1.68M 1.5M 1.44M 1.36M 1.34M 1.22M 1.19M 1.18M 1.14M 1.14M 1.14M 1.14M 1.1M
EPS (Basic)
-2.84 -3.32 -3.68 -4.22 -5.4 -7.04 -8.24 -9.35 -10.11 -9.69 -9.99 -10.55 -10.4 -11.37 -11.21 -11.53 -13.63 -17.46
EPS (Diluted)
-2.5 -2.98 -3.34 -4.22 -5.4 -7.04 -8.24 -9.35 -10.11 -9.69 -9.99 -10.55 -10.4 -11.37 -11.21 -11.53 -13.63 -17.46
EBITDA
-8.71M -8.39M -7.85M -7.61M -8.44M -10.24M -11.56M -12.49M -12.95M -12M -11.82M -12.26M -11.92M -12.92M -12.56M -12.1M -13.23M -13.32M
EBIT
-8.85M -8.45M -8M -7.76M -8.61M -10.41M -11.64M -12.58M -13.04M -12.08M -11.9M -12.34M -11.98M -12.98M -12.62M -12.16M -13.3M -13.38M
Depreciation & Amortization
147K 60K 154K 159K 164K 248K 243K 320K 403K 391K 377K 295K 350K 416K 478K 479K 336K 195K